SCHEMBL20567971

SCHEMBL20567971

Cc1ccc(C(=O)Nc2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Oc1ccnc2c1OCCCN2

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAP4K2 Q12851 4/20 0.62
MAP3K7 O43318 3/20 0.62
KIT P10721 3/20 0.52
CSF1R P07333 3/20 0.52
LYN P07948 1/20 0.52
ABL1 P00519 3/20 0.51
LDLR P01130 3/20 0.48
PCSK9 Q8NBP7 3/20 0.48
PDGFRB P09619 2/20 0.48
BRAF P15056 5/20 0.47
SRC P12931 2/20 0.46
HCK P08631 1/20 0.46
NR2C2 P49116 1/20 0.46
BTK Q06187 1/20 0.46
DDR1 Q08345 1/20 0.44
DDR2 Q16832 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20570160 0.96 MAP4K2 (0.63) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568959 0.89 MAP4K2 (0.55) MAP4K2MAP3K7KITCSF1RABL1
SCHEMBL20569395 0.88 MAP4K2 (0.54) MAP4K2MAP3K7KITLYNABL1
SCHEMBL20568260 0.88 MAP3K7 (0.53) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568290 0.87 MAP4K2 (0.53) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568408 0.87 MAP4K2 (0.69) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568526 0.84 MAP4K2 (0.49) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568529 0.84 MAP4K2 (0.49) MAP4K2MAP3K7KITCSF1RLYN
SCHEMBL20568682 0.80 MAP4K2 (0.60) MAP4K2MAP3K7KITCSF1RABL1
SCHEMBL20569381 0.80 KDR (0.48) MAP4K2MAP3K7BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601752-A Novel inhibitors of MAP4K1 伊克诺斯科学公司 2021-04-02 CN claimed
EP-3630778-A1 NOVEL INHIBITORS OF MAP4K1 Ichnos Sciences SA (CH) 2020-04-08 EP claimed
WO-2018215668-A1 NOVEL INHIBITORS OF MAP4K1 GLENMARK PHARMACEUTICALS S.A. (CH) 2018-11-29 WO claimed